Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7176283
Protease-activated receptor 3 and uses thereof
granted -
US 7176201
Modulation of anxiety through blockade of anandamide hydrolysis
granted -
US 7172761
Polyvalent immunogen
granted -
US 7166578
Orally administered peptides synergize statin activity
granted -
US 7163806
Somatic cells with ablated PrP gene and methods of use
granted -
US 7163686
Protein A based binding domains with desirable activities
granted -
US 7157435
Methods for modulation of the effects of aging on the primate brain
granted -
US 7157439
HoxD3, HoxA3, and HoxB3 compositions and methods for improved wound healing
granted -
US 7153936
Semaphorin gene family
granted -
US 7153509
Immunogenic peptides comprising a T-helper epitope and a B-cell neutralizing antibody epitope
granted -
US 7150871
Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6
granted -
US 7151100
Indole compounds useful for the treatment of cancer
granted -
US 7148201
Use of human plasma hyaluronidase in cancer treatment
granted -
US 7148197
Orally administered small peptides synergize statin activity
granted -
US 7144723
Marine actinomycete taxon for drug and fermentation product discovery
granted -
US 7144862
Orally administered peptides to ameliorate atherosclerosis
granted -
US 7141603
Antitumor agents
granted -
US 7138237
Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen
granted -
US 7138384
Modulators of DNA cytosine-5 methyltransferase and methods for use thereof
granted -
US 7135177
Immunoliposomes that optimize internalization into target cells
granted -
US 7135192
Cationic lipid compositions targeting angiogenic endothelial cells
granted -
US 7132122
Direct micro-patterning of lipid bilayers using UV light and selected uses thereof
granted -
US 7132454
HEXIM1 as a suppressor of HIV replication and cardiac hypertrophy
granted -
US 7132403
Antihelminthic anthraquinones and method of use thereof
granted